Your browser doesn't support javascript.
loading
Impact of viral hepatitis therapy in multiple myeloma and other monoclonal gammopathies linked to hepatitis B or C viruses.
Rodríguez-García, Alba; Mennesson, Nicolas; Hernandez-Ibarburu, Gema; Morales, María Luz; Garderet, Laurent; Bouchereau, Lorine; Allain-Maillet, Sophie; Piver, Eric; Marbán, Irene; Rubio, David; Bigot-Corbel, Edith; Martínez-López, Joaquín; Linares, María; Hermouet, Sylvie.
Afiliação
  • Rodríguez-García A; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, ES 28041, Madrid.
  • Mennesson N; Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, F-44000 Nantes.
  • Hernandez-Ibarburu G; Biomedical Informatics Group, Universidad Politécnica de Madrid, Madrid, Spain; TriNetX LLC, Madrid.
  • Morales ML; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, ES 28041, Madrid.
  • Garderet L; Sorbonne Université-INSERM, UMR_S 938, Centre de Recherche Saint-Antoine-Team Hematopoietic and leukemic development, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpetrière, Département d'Hématologie et de Thérapie Cellulaire, F-75013 Paris.
  • Bouchereau L; Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, F-44000 Nantes.
  • Allain-Maillet S; Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, F-44000 Nantes.
  • Piver E; Laboratoire de Biochimie, CHU Tours, Tours, France; Inserm UMR1253, MAVIVH Tours.
  • Marbán I; Biomedical Informatics Group, Universidad Politécnica de Madrid, Madrid.
  • Rubio D; Biomedical Informatics Group, Universidad Politécnica de Madrid, Madrid, Spain; TriNetX LLC, Madrid.
  • Bigot-Corbel E; Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, F-44000 Nantes, France; Laboratoire de Biochimie, CHU Nantes, F-44000, Nantes.
  • Martínez-López J; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, ES 28041, Madrid, Spain; Department of Medicine, Medicine School, Universidad Complutense de Madrid, ES 28040, Madrid.
  • Linares M; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, ES 28041, Madrid, Spain; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, ES 2
  • Hermouet S; Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, F-44000 Nantes, France; Laboratoire d'Hématologie, CHU Nantes, F-44000, Nantes. sylvie.hermouet@univ-nantes.fr.
Haematologica ; 109(1): 272-282, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-37199121
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Hepatite C / Hepatite B / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Gamopatia Monoclonal de Significância Indeterminada / Hepatite C / Hepatite B / Mieloma Múltiplo Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2024 Tipo de documento: Article